Skip to content
Governance Register

← US public companies

Celsus Therapeutics Plc.

SEC CIK 1541157 · CLTX · last insider filing 2026-06-25

Directors (from insider filings)

NameCapacity as filedFilings
Gaslightwala Abizer Director · President & CEO filed 2024 - 2026
Neal James R Director filed 2024 - 2026
Huh Hoyoung Director filed 2024 - 2025
Bazemore Robert B Director filed 2024 - 2025
Prudo-Chlebosz Raymond Director filed 2015 - 2025
Patel Samir Rashmikant Director filed 2024 - 2025
Patel Sandip I Director filed 2024 - 2025
Williams Donald A Director filed 2024 - 2024
Grissinger Michael Director filed 2024 - 2024
Hashad Mohamed Wa'el Ahmed Director filed 2024 - 2024
Jacques Rachelle Suzanne Director · Chief Executive Officer filed 2024 - 2024
Williams Donald Allen Director filed 2016 - 2016
Cohen Mark S Director filed 2015 - 2016
Hill James Director filed 2015 - 2016
Ungar Stuart Director filed 2015 - 2016
Byrne David Director filed 2016 - 2016
Shaw Allan Director filed 2015 - 2015
Richardson Clive Director · COO filed 2015 - 2015
Roshwalb Gur Director · Chief Executive Officer filed 2015 - 2015
Eiran Amos Director filed 2015 - 2015
LAU Johnson YIU NAM Director filed 2015 - 2015
Sidransky David Director filed 2015 - 2015
Doman Robert F Director filed 2015 - 2015

Officers (from insider filings)

NameTitle as filedFilings
Farag Kameel D. Interim CFO filed 2025 - 2026
Hombeck Torsten CFO filed 2024 - 2025
Dicicco Wendy F Interim CFO filed 2024 - 2024
Shaw Robert M General Counsel and Secretary filed 2016 - 2016
Elefant Dov Chief Financial Officer filed 2015 - 2015
Jimenez Pablo Chief Medical Officer filed 2015 - 2015

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.